Cassava Sciences, Inc.
SAVA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $140,533 | $87,437 | $72,393 | $113,514 |
| - Cash | $0 | $112,381 | $117,328 | $128,574 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $140,533 | -$24,944 | -$44,935 | -$15,060 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$200 | -$5,116 | -$13,666 | -$20,530 |
| % Margin | – | – | – | – |
| EBITDA | -$10,607 | -$13,874 | -$21,366 | -$19,327 |
| % Margin | – | – | – | – |
| Net Income | -$10,807 | -$44,224 | -$23,403 | -$27,597 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.22 | -0.92 | -0.48 | -0.57 |
| % Growth | 76.1% | -91.7% | 15.8% | – |
| Operating Cash Flow | -$6,221 | -$4,947 | -$11,336 | -$61,265 |
| Capital Expenditures | -$80 | $0 | $0 | -$57 |
| Free Cash Flow | -$6,301 | -$4,947 | -$11,336 | -$61,322 |